Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

Completed

• Conditions: Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder

• Registration Number: NCT00749970
• Lead Sponsor: AstraZeneca

Brief Summary

Observational, short-term prospective, multicenter study to assess psychometric properties of the Spanish version of SWN-K scale in patients with schizophrenia.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07
• Study First Submitted: 2008-09-09
• Study First Submitted QC: 2008-09-09
• Study First Posted: 2008-09-10
• Primary Completion: 2009-01
• Study Completion: 2009-01
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-08
• Last Update Posted: 2010-12-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients with a diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder (DSM-IV TR criteria)
• Stabilized out-patients
• Under treatment with an oral antipsychotic drug

Read More

Exclusion Criteria

• Administration of a depot antipsychotic drug
• Participation in another clinical trial within 4 weeks prior to enrolment into this study

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SWN-K	7 days
PANSS	7 days

Secondary Outcome Measures

Name	Time	Method
CGI-I	7 days

Trial Locations

Locations (2)

Research site; 🇪🇸 Tarragona, Spain

Research Site; 🇪🇸 Zaragoza, Spain